Home » Newsletters » BioWorld

BioWorld

June 10, 1994

View Archived Issues

CANGENE'S BOARD TO MEET ON PHARMA PATCH OFFER

CARRINGTON GIVEN OK FOR AIDS TRIAL

MERCK PROVIDES VACCINE TECHNOLOGY TO CHINA

ARRIS FOCUSES ON INHIBITING TRYPTASE

BIOMUNE COMPLETES $5.4M PLACEMENT

NEW COMPANY TO TRANSPLANT HUMAN ISLET CELLS

CAMBRIDGE BIOTECH'S STOCK DELISTED DUE TO AUDIT

LIDAK NETS $8.3M FROM WARRANTS

CLEVELAND CLINIC TURNS RESEARCH INTO ANTISENSE COMPANY

RAC APPROVES GENE THERAPY PROTOCOL FOR ARTHRITIS

FDA PANEL RECOMMENDS APPROVAL OF CENTOCOR'S REOPRO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 3, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...